Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001096906-09-001139
Filing Date
2009-09-24
Accepted
2009-09-24 12:45:20
Documents
4
Period of Report
2007-06-30

Document Format Files

Seq Description Document Type Size
1 CHINA AOXING PHARMACEUTICAL COMPANY, INC. FORM 10-K/A JUNE 30, 2007 caxg10ka20070630.htm 10-K/A 1147729
2 RULE 13A-14(A) CERTIFICATION - CEO caxg10ka20070630ex31-1.htm EX-31.1 9013
3 RULE 13A-14(A) CERTIFICATION - CFO caxg10ka20070630ex31-2.htm EX-31.2 8895
4 RULE 13A-14(B) CERTIFICATION- ZHENJIANG YUE caxg10ka20070630ex32.htm EX-32 6061
  Complete submission text file 0001096906-09-001139.txt   1173334
Mailing Address 40 WALL STREET, 28TH FLOOR NEW YORK NY 10005
Business Address 40 WALL STREET, 28TH FLOOR NEW YORK NY 10005 646-512-5662
CHINA AOXING PHARMACEUTICAL COMPANY, INC. (Filer) CIK: 0001060426 (see all company filings)

EIN.: 650636168 | State of Incorp.: FL | Fiscal Year End: 0630
Type: 10-K/A | Act: 34 | File No.: 001-32674 | Film No.: 091084224
SIC: 2834 Pharmaceutical Preparations